125 related articles for article (PubMed ID: 1972973)
41. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
42. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
43. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
44. Unilateral injections of a D2 but not D1 agonist into the frontal cortex of rats produce a contralateral directional bias.
Beninger RJ; Musgrave MA; Dickson PR
Pharmacol Biochem Behav; 1990 Nov; 37(3):387-92. PubMed ID: 1982354
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
46. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
Asin KE; Montana WE
Pharmacol Biochem Behav; 1989 Apr; 32(4):1033-41. PubMed ID: 2572001
[TBL] [Abstract][Full Text] [Related]
47. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
48. Effect of Gi protein ADP-ribosylation induced by pertussis toxin on dopamine-mediated behaviors.
Marin C; Parashos SA; Chase TN
Eur J Pharmacol; 1991 Mar; 195(1):19-25. PubMed ID: 1676678
[TBL] [Abstract][Full Text] [Related]
49. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
Robertson HA; Peterson MR; Murphy K; Robertson GS
Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
[TBL] [Abstract][Full Text] [Related]
50. Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance.
Levin ED; Rose JE
Pharmacol Biochem Behav; 1991 Feb; 38(2):243-6. PubMed ID: 1676165
[TBL] [Abstract][Full Text] [Related]
51. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
Ajima A; Yamaguchi T; Kato T
Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
[TBL] [Abstract][Full Text] [Related]
52. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.
Eilam D; Clements KV; Szechtman H
Behav Brain Res; 1991 Nov; 45(2):117-24. PubMed ID: 1686397
[TBL] [Abstract][Full Text] [Related]
53. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
54. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
Evans AM; Green KL
Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
[TBL] [Abstract][Full Text] [Related]
55. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
Zhou LW; Zhang SP; Qin ZH; Weiss B
J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
[TBL] [Abstract][Full Text] [Related]
56. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
Jiang LH; Kasser RJ; Altar CA; Wang RY
J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
[TBL] [Abstract][Full Text] [Related]
57. The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Millan MJ; Bervoets K; Mavridis M
Neurosci Lett; 1991 Sep; 130(2):173-6. PubMed ID: 1795876
[TBL] [Abstract][Full Text] [Related]
58. Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
Nikulina EM; Skrinskaya JA; Popova NK
Psychopharmacology (Berl); 1991; 105(4):525-9. PubMed ID: 1685251
[TBL] [Abstract][Full Text] [Related]
59. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.
White NM; Packard MG; Hiroi N
Psychopharmacology (Berl); 1991; 103(2):271-6. PubMed ID: 1674160
[TBL] [Abstract][Full Text] [Related]
60. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
Olsson M; Nikkhah G; Bentlage C; Björklund A
J Neurosci; 1995 May; 15(5 Pt 2):3863-75. PubMed ID: 7751951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
